Exicure just reported results for the second quarter of 2024. More
Articles
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q2 2024
ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
CTNM Stock Earnings: Contineum Therapeutics Misses EPS for Q2 2024
CTNM stock results show that Contineum Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
ANRO Stock Earnings: Alto Neuroscience Beats EPS for Q2 2024
ANRO stock results show that Alto Neuroscience beat analyst estimates for earnings per share the second quarter of 2024. More
MNR Stock Earnings: Mach Natural Resources Misses EPS, Misses Revenue for Q2 2024
MNR stock results show that Mach Natural Resources missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
RDZN Stock Earnings: Roadzen Misses EPS, Misses Revenue for Q1 2025
RDZN stock results show that Roadzen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025. More
ARMP Stock Earnings: Armata Pharmaceuticals Beats EPS for Q2 2024
ARMP stock results show that Armata Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. More
